CTOs on the Move

r937.com

www.r937.com

 
r937.com is a East York, ON-based company in the Computers and Electronics sector.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.r937.com
  • 127 Glenwood Cres
    East York, ON CAN M4B 1J9
  • Phone: 416.751.0937

Executives

Name Title Contact Details

Similar Companies

GlassHouse Technologies

GlassHouse Technologies, Inc is a Framingham, MA-based company in the Computers and Electronics sector.

I2V

I2V Inc. is a Laval, QC-based company in the Computers and Electronics sector.

ecoATM

ecoATM/Gazelle is the global leader in mobile device recommerce. ecoATM/Gazelle offers the leading technology platform for convenient, quick, environmentally responsible, and secure sale and recommerce of used devices online at gazelle.com and in person at more than 5000 convenient retail kiosk locations in the US, UK, France and Germany. The technology makes selling a used device easy, with assurance that devices will be responsibly reused or recycled. Over 33 million devices have been purchased, resold, refurbished, and recycled with ecoATM/Gazelle, diverting millions of tons of plastic, chemicals and toxins from landfills around the world.

Bostrom

Bostrom is a professional services firm offering comprehensive management, consulting and outsourcing to the not-for-profit community. For more than eight decades Bostrom has provided associations with the solutions they need to grow, stabilize, redirect, consolidate and meet challenging goals.

Patient Discovery

Patient Discovery`s mission is to transform the way all patients are understood, supported and treated, and provide a platform for patients` real-world experiences to be integrated into decision-making throughout the entire healthcare ecosystem. Our patient-provider engagement platform brings to the forefront non-clinical factors that both allow providers to efficiently create better patient-centric and standard care plans, and enable health systems, pharma, and payers to effectively make informed decisions based on aggregated, real-world patient insights.